Tools


Sitemap

Sitemap

Infectious Disease Testing Case Studies

3 items 1 - 3
  1. National Transfusion Service of Slovakia chooses the Quadriga BeFree System,Enzygnost (ELISA) Assays
    2017-06-01

    National Transfusion Service of Slovakia chooses the Quadriga BeFree System,Enzygnost (ELISA) Assays

    National Transfusion Service of Slovakia chooses the Quadriga BeFree System,Enzygnost (ELISA) Assays

    • Clinical Content Case Studies
    • Product Lines Infectious Disease Testing
    • Clinical Specialties & Diseases Infectious Disease
  2. Interregional Blood Transfusion SRC chooses Enzygnost (ELISA) Anti-HCV 4.0 assay and Quadriga BeFree System
    2015-09-01Siemens Healthcare Diagnostics, Inc.

    Interregional Blood Transfusion SRC chooses Enzygnost Anti-HCV 4.0 assay and Quadriga BeFree System

    Fewer confirmation tests needed. Less destruction of false-reactive blood components.

    • Clinical Content Case Studies
    • Product Lines Infectious Disease Testing
    • Clinical Specialties & Diseases Infectious Disease
  3. Bavarian Red Cross Chooses Siemens Quadriga BeFree System to Ensure Safety of Blood Supply
    2014-08-21

    Bavarian Red Cross Chooses Siemens Quadriga BeFree System to Ensure Safety of Blood Supply

    Bavarian Red Cross Chooses Siemens Quadriga BeFree System to Ensure Safety of Blood Supply

    • Clinical Content Case Studies
    • Product Lines Infectious Disease Testing
    • Clinical Specialties & Diseases Infectious Disease
3 items 1 - 3

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

Did this information help you?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you